ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Assisted Reproductive Technology Global Market Analysis Report 2025 | Opportunities Emerge with Growing Number of Fertility Clinics and Growth in Emerging Economies - Forecast to 2030 - ResearchAndMarkets.com

The "Assisted Reproductive Technologies Market" report has been added to ResearchAndMarkets.com's offering.

The report provides an analysis of the global assisted reproductive technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented into procedure, product, end user, and region. The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape.

This short report provides an overview of the global assisted reproductive technologies market and analyzes market trends. The report includes global revenue ($ millions) for base year data (2024), estimated data for 2025, and forecasts of compound annual growth rates (CAGRs) from 2025 through 2030.

Based on procedures, the market is segmented into in vitro fertilization (IVF), artificial insemination and others. The IVF procedure segment is further sub-segmented based on procedure type into frozen non-donor, fresh non-donor, frozen donor and fresh donor. Based on product, the assisted reproductive technologies market is divided into instruments, reagents and media, accessories and disposables. The market is segmented into fertility clinics, hospitals, and others based on end users. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape. It concludes with an analysis of the competitive landscape of prominent companies in the global assisted reproductive technologies market. It also has a dedicated section of company profiles that covers details such as overview, product portfolio and strategic developments of major companies in the market.

Report Includes

  • Overview and analysis of the global markets for assisted reproductive technologies (ART)
  • Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects of the global ART market, and a corresponding market share analysis based on product type, technology (procedure) type, end user and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impacts of macroeconomic variables
  • Discussion of the underlying opportunities and potential, with the integration of emerging networks of fertility clinic services, reproductive drugs and ongoing research activities in reproductive medicine
  • Insights derived from Porter's Five Forces model, global supply chain analyses and case studies
  • An analysis of patents, emerging trends and the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Profiles of the Leading Companies

  • Cook
  • Coopersurgical Inc.
  • Esco Medical
  • Fertipro Nv
  • Genea Biomedx
  • Hamilton Thorne
  • Invitrocare Inc.
  • Kitazato Corp.
  • Nidacon International Ab
  • Vitrolife Ab

Key Attributes:

Report Attribute Details
No. of Pages 80
Forecast Period 2025 - 2030
Estimated Market Value (USD) in 2025 $35.4 Billion
Forecasted Market Value (USD) by 2030 $53.8 Billion
Compound Annual Growth Rate 7.5%
Regions Covered GlobalĀ 

Key Topics Covered:

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Market Definition
  • Types of ART
  • Technology Background
  • Controlled Ovarian Stimulation
  • Gonadotropin-Releasing Hormone (GnRH) Antagonist and Agonist Cycles
  • Oocyte Retrieval
  • Fertilization
  • Preimplantation Genetic Testing (PGT)
  • In Vitro Maturation
  • Embryo Transfer
  • Equipment
  • PESTEL Analysis
  • Impact of U.S. Tariff Laws on the Assisted Reproductive Technologies Market
  • Effects on Supply Chains
  • Opportunities for Local Production
  • Conclusion

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rising Infertility Rates
  • Technological Advances in ART
  • Increasing Awareness and Acceptance Regarding Fertility Treatments
  • Market Restraints
  • High Costs of Treatment
  • Ethical and Legal Issues
  • Market Opportunities
  • Growing Number of Fertility Clinics
  • Growth Opportunities in Emerging Economies

Chapter 4 Emerging Technologies and Developments

  • Key Takeaways
  • Artificial Womb Facility
  • Artificial Intelligence-Based IVF
  • AI in Gamete Selection
  • AI in Embryo Selection
  • AI in Treatment Routine

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Breakdown by Procedure
  • Key Takeaways
  • In Vitro Fertilization
  • IVF Market, by Procedure Sub-Type
  • Artificial Insemination
  • Other Procedures
  • Market Breakdown by Product
  • Key Takeaways
  • Instruments
  • Reagents and Media
  • Accessories and Disposables
  • Market Breakdown by End User
  • Key Takeaways
  • Fertility Clinics
  • Hospitals
  • Other End Users
  • Geographic Breakdown
  • Market Breakdown by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Key Takeaways
  • Key Companies in the Assisted Reproductive Technologies Market
  • Strategic Analysis
  • Collaborations and Partnerships
  • Acquisitions and Investments
  • Product Approvals

Chapter 7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/j9skt4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.